Revive Therapeutics Ltd. (RVV.CX)
0.03
0.00 (0.00%)
CAD |
CNSX |
Aug 26, 14:07
Revive Therapeutics Total Liabilities (Quarterly) : 4.306M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.306M |
| December 31, 2025 | 4.001M |
| September 30, 2025 | 3.751M |
| June 30, 2025 | 3.661M |
| March 31, 2025 | 3.686M |
| December 31, 2024 | 3.321M |
| September 30, 2024 | 3.289M |
| June 30, 2024 | 3.404M |
| March 31, 2024 | 3.325M |
| December 31, 2023 | 3.346M |
| September 30, 2023 | 3.518M |
| June 30, 2023 | 3.599M |
| March 31, 2023 | 3.921M |
| December 31, 2022 | 4.331M |
| September 30, 2022 | 3.725M |
| June 30, 2022 | 4.463M |
| March 31, 2022 | 3.334M |
| December 31, 2021 | 1.414M |
| September 30, 2021 | 3.871M |
| June 30, 2021 | 0.9997M |
| March 31, 2021 | 1.011M |
| December 31, 2020 | 0.8895M |
| September 30, 2020 | 0.713M |
| June 30, 2020 | 0.8316M |
| March 31, 2020 | 1.353M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.7709M |
| September 30, 2019 | 0.8822M |
| June 30, 2019 | 0.3218M |
| March 31, 2019 | 0.262M |
| December 31, 2018 | 0.2733M |
| September 30, 2018 | 0.2699M |
| June 30, 2018 | 0.2993M |
| March 31, 2018 | 0.3119M |
| December 31, 2017 | 0.2934M |
| September 30, 2017 | 0.3603M |
| June 30, 2017 | 0.3085M |
| March 31, 2017 | 0.2771M |
| December 31, 2016 | 0.4075M |
| September 30, 2016 | 0.6099M |
| June 30, 2016 | 0.8184M |
| March 31, 2016 | 0.6506M |
| December 31, 2015 | 0.4437M |
| September 30, 2015 | 0.4506M |
| June 30, 2015 | 0.3044M |
| March 31, 2015 | 0.1872M |
| December 31, 2014 | 0.1254M |
| September 30, 2014 | 0.1452M |
| June 30, 2014 | 0.0778M |
| March 31, 2014 | 0.0361M |
| December 31, 2013 | 0.2101M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 104.01M |
| Bausch Health Cos., Inc. | 36.31B |
| Cipher Pharmaceuticals, Inc. | 27.86M |
| BioSyent, Inc. | 14.62M |
| Knight Therapeutics, Inc. | 246.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.2818M |
| Shareholders Equity (Quarterly) | -4.025M |
| Debt to Equity Ratio | -0.0176 |
| Current Ratio | 0.0359 |
| Net Debt Paydown Yield | -0.09% |